Publications Database

Akhondzadeh S. et al. (2008)

A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder.

Child Psychiatry and Human Development

39(3), pp. 237-245

Read Abstract (New Window)

Angley M. T. et al. (2007)

Children and autism: Part 2: management with complementary medicines and dietary interventions.

Australian Family Physician

36(10), pp. 827-830

Read Abstract (New Window) Read Full (New Window)

Arnold G. et al. (2003)

Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies.

Journal of Autism and Developmental Disorders

33(4), pp. 449-454

Read Abstract (New Window)

Bolman W. M. , Richmond J. (1999)

A double-blind, placebo-controlled crossover pilot trial of low dose dimethylglycine in patients with autistic disorder.

Journal of Autism and Developmental Disorders

29(3), pp. 191-194

Read Abstract (New Window)

Boris M. , Goldblatt A. , Edelson S. M. (2006)

Improvement in children with autism treated with intravenous gamma globulin.

Journal of Nutritional and Environmental Medicine

15(4), 169-176

Read Abstract (New Window) Read Full (New Window)

University of Maryland Medical Center (2011)

Carnitine (L-carnitine)

Baltimore, MD: University of Maryland Medical Center

Read Full (New Window)

University of Maryland Medical Center (2011)

Glutamine

Baltimore, MD: University of Maryland Medical Center

Read Full (New Window)

University of Maryland Medical Center (2011)

Phenylalanine

Baltimore, MD: University of Maryland Medical Center

Read Full (New Window)

Chez M. G. et al. (2002)

Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders.

Journal of Child Neurology

17(11), pp. 833-837

Read Abstract (New Window)

Frye R. E. , Sreenivasula S. , Adams J. B. (2011)

Traditional and non-traditional treatments for autism spectrum disorder with seizures: an on-line survey.

BMC Pediatrics

11(1), pp. 37

Read Abstract (New Window) Read Full (New Window)

Kern J. K. et al. (2001)

Effectiveness of N,N-dimethylglycine in autism and pervasive developmental disorder.

Journal of Child Neurology

16(3), pp. 169-173

Read Abstract (New Window)

Kidd P. M. (2002)

Autism, an extreme challenge to integrative medicine. Part II: medical management.

Alternative Medicine Review

December, 7(6), pp. 472-499

Read Abstract (New Window) Read Full (New Window)

de Koning T. J. et al. (2003)

L-serine in disease and development.

Biochemical Journal

371(3), pp. 653-661

Read Abstract (New Window) Read Full (New Window)

Ospina M. B. et al. (2008)

Behavioural and developmental interventions for autism spectrum disorder: a clinical systematic review.

PLoS ONE

3(11), e3755

Read Abstract (New Window) Read Full (New Window)

Parr J. R. (2008)

Autism.

Clinical Evidence (Online)

pii: 0322

Read Abstract (New Window)

Ratajczak H. (2011)

Theoretical aspects of autism: biomarkers: a review.

Journal of Immunotoxicology

8(1), pp. 80-94.

Read Abstract (New Window)

University of Maryland Medical Center (2011)

Cysteine.

Baltimore, MD: University of Maryland Medical Center

Read Full (New Window)

University of Maryland Medical Center (2010)

Immune globulin (Injection).

Baltimore, MD: University of Maryland Medical Center

Read Full (New Window)

White C. et al. (2010)

Therapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders.

CNS and Neurological Disorder Drug Targets

9(5), pp. 661-666.

Read Abstract (New Window) Read Full (New Window)